Effects of Celecoxib and Nimesulide on the Proliferation of Ectopic Endometrial Stromal Cells in vitro

Abstract

The effects of cyclooxygenase 2 (COX-2) selective inhibitors on the proliferation of ectopic endometrial stromal cells in vitro were investigated. Ectopic endometrial stromal cells were treated with either celecoxib or nimesulide for 24 and 48 h. The results showed that (i) both celecoxib and nimesulide inhibited the proliferation of ectopic endometrial stromal cells in vitro in a time- and dose-dependent manner; (ii) the expression of prostaglandin E₂ was significantly inhibited by both celecoxib and nimesulide in a dose-dependent manner; (iii) the percentage of apoptotic cells was significantly higher for cells treated with celecoxib or nimesulide than for untreated cells; and (iv) the percentage of the cells in the G₀/G₁ phase increased after the cells were treated with either agent in a dose-dependent manner. These data suggest that celecoxib and nimesulide inhibited proliferation of ectopic endometrial stromal cells by inducing apoptosis and blocking the cell cycle at the G₀/G₁ phase.

Keywords

Celecoxib Nimesulide Cyclooxygenase 2 (COX-2) Inhibitors Endometriosis Apoptosis Cell Proliferation

References

Huang

Shen

Wei

: Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. World J Gastroenterol 2005; 11: 204–207.

Mohseni

Zaslau

McFadden

: COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro . J Surg Res 2004; 119: 138–142.

Swiersz

: Role of endometriosis in cancer and tumor development. Ann NY Acad Sci 2002; 955: 281–292.

Chishima

Hayakaw

Sugita

: Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Rep Immunology 2002; 48: 50–56.

Attar

Bulun

: Aromatase and other steroid-ogenic genes in endometriosis: Translational aspects. Hum Reprod Update 2006; 12: 49–56.

Laschke

Elitzsch

Scheuer

: Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 2007; 87: 163–171.

Larkins

Nowell

Singh

: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006; 6: 181.

Shoji

Chuang

: Endometriosis: Disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 2007; 9: 1–20.

Frampton

Keating

: Celecoxib: A review of its use in the management of arthritis and acute pain. Drugs 2007; 67: 2433–2472.

10.

Huskisson

: Nimesulide, a balanced drug for the treatment of osteoarthritis. Clin Exp Rheumatol 2001; 19 (1 suppl 22): S21–S25.

11.

Harada

Suganuma

Furuhashi

: Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 1996; 2: 307–315.

12.

Hsu

Ching

Wang

: The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 2000; 275: 11397–11403.

13.

Sheng

Shao

Morrow

: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362–366.

14.

Zhang

Park

: Role of BAX in the apoptotic response to anticancer agents. Science 2000; 290: 989–992.

15.

Baek

Hur

Wang

: Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol 2007; 13: 1175–1181.

16.

Amrite

Kompella

: Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism. J Pharmacol Exp Ther 2008; 324: 749–758.

17.

FitzGerald

Patrono

: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433–442.